Racial Differences in Survival of Elderly Adults with Chronic Myeloid Leukemia Before and After the Introduction of Imatinib in the United States.
Cancer Center and Blood Institute, St. Joseph Regional Medical Center, Lewiston, Idaho.
Binay Kumar
BK
Shah
Abington Memorial Hospital, Abington, Pennsylvania.
Dipesh
D
Uprety
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000208:ethnology* / Q000401:mortality*; D008297:Male; D018426:SEER Program; D015996:Survival Rate; D014481:United States
D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate